Published in PLoS One on December 30, 2015
Advancing HIV prevention: new strategies for a changing epidemic--United States, 2003. MMWR Morb Mortal Wkly Rep (2003) 9.37
Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS (2006) 3.70
Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS (2006) 2.85
Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS One (2010) 2.10
Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol (2008) 1.97
Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol (2003) 1.66
Enrollment characteristics and risk behaviors of injection drug users participating in the Bangkok Tenofovir Study, Thailand. PLoS One (2011) 1.40
Rapid HIV screening: missed opportunities for HIV diagnosis and prevention. J Clin Virol (2012) 1.38
Viral load differences in early infection with two HIV-1 subtypes. AIDS (2001) 1.34
State of the art for diagnosis of HIV infection. Clin Infect Dis (2007) 1.34
Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco. PLoS One (2013) 1.07
HIV pre-exposure prophylaxis and health and community systems in the Global South: Thailand case study. J Int AIDS Soc (2015) 0.89
Risk behaviors and risk factors for HIV infection among participants in the Bangkok tenofovir study, an HIV pre-exposure prophylaxis trial among people who inject drugs. PLoS One (2014) 0.83
Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study. Lancet HIV (2016) 0.76